2021 MedCan Speaker

Mitch Cuevas

Pharmaceutical Director,
Eqalis

Mitch is an experienced CEO & Executive Director with a demonstrated history of working in and delivering value to FMCG, pharmaceutical & manufacturing industries, most specifically in food, pharmaceuticals, personal care / health care sectors.

He was the Managing Director of API Consumer Brands, an Auckland based high-end manufacturer and distributer of pharmaceuticals, wellness products and consumer toiletries. API (NZ) has a turnover over $70M+, 250+ staff, with markets in NZ, Australia and Asia. With its two manufacturing plants, it’s the largest manufacturer of controlled substances (medicines) in the Southern Hemisphere and the largest supplier of analgesics (pain medications) to the NZ market. It supplies to Pharmac (NZ), pharmacy and retail in NZ, Australia and across Asia.
Mitch’s commercial career has been centred on consumer goods, financial performance management and manufacturing for 25+ years. He has been actively involved in a number of M&A activities, export expansions and successful business “commercial rescues”.

In NZ, Mitch has also held senior management/CEO positions at some of NZ’s most respected companies – Fonterra, Air NZ, Goodman Fielder and Ecostore.

Prior to arriving in New Zealand in 2002 he had lived in the UK, Brazil, Spain and the USA and had worked for (or consulted to) several global companies including: Unilever, Cadbury Schweppes, Ericsson, United Airlines, Heineken, Kelloggs, Nabisco, Telefonica and Ford Motor Group.

He earned his BA in International Business from San Diego State University in ‘92, an MBA from London Business School in ‘97, and General Management from Harvard Business School in ’04.

Mitch is a Director at the CEO Institute, a member of Young Presidents Association (YPO Global) and NZ Institute of Directors(IOD) and a past lecturer on Leadership. He is also fluent in both Spanish and Portuguese.


All Sessions by Mitch Cuevas

Day 1 - Industry Summit - 10 February

Time Industry Stream Science Stream
09:50
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Rob Mitchell 
Chief Executive Officer, Rua Bioscience
Mark Lucas 
Chief Executive Officer, Cannasouth
Tim Aldridge 
Managing Director, Puro
Mitch Cuevas 
Pharmaceutical Director, Eqalis
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Rob Mitchell 
Chief Executive Officer, Rua Bioscience
Mark Lucas 
Chief Executive Officer, Cannasouth
Tim Aldridge 
Managing Director, Puro
Mitch Cuevas 
Pharmaceutical Director, Eqalis

More Speakers

Richard Keene

Principal

Simon Yarrow

Group Manager, Agrifood

Elizabeth Plant

Chief Medical Officer